Japan Medical Device Regulatory Requirements for Overseas Manufacturers

A practical overview of key regulatory considerations for market entry

Japan is an important market for medical device manufacturers, but regulatory requirements must be reviewed carefully before market entry. For overseas manufacturers, Japan medical device regulatory requirements may involve product classification, approval or certification pathway, local marketing authorization structure, QMS, foreign manufacturer registration, labeling, clinical evaluation and post-market obligations.

Key Regulatory Questions Before Entering Japan

Is the product considered a medical device in Japan?

What is the Japanese medical device classification?

Is the pathway notification, certification or approval?

Is PMDA consultation necessary?

Is a local MAH (Marketing Authorization Holder) required?

What are the QMS (Quality Management System) requirements?

Is a Clinical Evaluation Report necessary?

What are the requirements for labeling and marketing materials?

Common Regulatory Issues for Overseas Manufacturers

Assuming overseas classification directly applies to Japan

Underestimating the necessity of clinical evaluation

Failing to establish a local MAH or DMAH structure

Insufficient understanding of Japan QMS requirements

Failure to conduct PMDA consultation in a timely manner

Labeling and marketing materials not compliant with Japan requirements

Overview of Japan Medical Device Regulatory Pathways

The regulatory pathway for a medical device in Japan depends on its classification. Generally, Class I devices may follow a notification pathway, certain Class II and Class III devices may follow a certification pathway when applicable standards exist, while other Class II and Class III devices and all Class IV devices typically require approval. Each pathway has different requirements, timelines and costs.

Marketing Authorization Holder (MAH) and DMAH

In Japan, medical devices must be marketed by a Marketing Authorization Holder (MAH) or Designated Representative (DMAH) with a physical presence in Japan. Many overseas manufacturers work with local partners to serve as the MAH. The MAH is responsible for regulatory compliance, post-market surveillance and adverse event reporting. Selecting an appropriate MAH is critical to successful market entry.

Quality Management System (QMS)

Japan requires medical device manufacturers to establish and maintain a Quality Management System. QMS requirements cover design, production, testing, labeling and storage. For certain devices, a QMS audit may be required. Ensuring that the QMS meets Japanese standards and PMDA expectations is critical for obtaining approval.

Clinical Evaluation Report (CER)

Many Japanese medical devices require a Clinical Evaluation Report. The CER should summarize existing clinical data and assess the product's safety and effectiveness. For certain devices, clinical trials may be necessary. The scope and depth of clinical evaluation depends on the product classification and intended use.

Foreign Manufacturer Registration

Overseas manufacturers must register in Japan. This involves submitting manufacturer information, product details and local representative information. Registration is a prerequisite for conducting PMDA consultation or submitting an approval application.

Labeling and Marketing Materials

Japan has specific requirements for medical device labeling and marketing materials. All labels must be in Japanese and include specific information such as intended use, contraindications, warnings and instructions for use. Marketing materials must be accurate and cannot make unsubstantiated claims.

PMDA Consultation

PMDA consultation is valuable for clarifying regulatory requirements and addressing technical questions. Different types of consultation are available, including product classification consultation, technical consultation and strategic consultation. Conducting consultation in a timely manner can help avoid delays and rework later in the process.

When to Seek Professional Assistance

When determining product classification

Before developing regulatory strategy

When preparing clinical evaluation documents

Before conducting PMDA consultation

When preparing approval applications

When selecting a local MAH or partner

Professional regulatory assistance can accelerate the market entry process and reduce risk.

Need Help with Japan Medical Device Regulatory Requirements?

MK Consulting supports medical device companies in reviewing Japan regulatory requirements, organizing regulatory documentation and business processes. We can help ensure your company complies with all applicable Japan regulatory requirements.

Contact MK Consulting